Baker Bros. Advisors as of March 31, 2020
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 110 positions in its portfolio as reported in the March 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Seattle Genetics | 35.6 | $5.8B | 50M | 115.38 | |
Incyte Corporation (INCY) | 14.4 | $2.3B | 32M | 73.23 | |
ACADIA Pharmaceuticals (ACAD) | 10.9 | $1.8B | 42M | 42.25 | |
Beigene (BGNE) | 8.9 | $1.4B | 12M | 123.11 | |
Alexion Pharmaceuticals | 4.8 | $787M | 8.8M | 89.79 | |
BioMarin Pharmaceutical (BMRN) | 3.9 | $641M | 7.6M | 84.50 | |
Kodiak Sciences (KOD) | 3.4 | $552M | 12M | 47.70 | |
Ascendis Pharma A S (ASND) | 2.4 | $382M | 3.4M | 112.61 | |
Igm Biosciences (IGMS) | 1.1 | $177M | 3.1M | 56.15 | |
Amarin Corporation (AMRN) | 0.8 | $138M | 35M | 4.00 | |
Argenx Se (ARGX) | 0.8 | $134M | 1.0M | 131.73 | |
Invitae (NVTAQ) | 0.8 | $124M | 9.1M | 13.67 | |
Principia Biopharma | 0.7 | $116M | 2.0M | 59.38 | |
Mirati Therapeutics | 0.7 | $108M | 1.4M | 76.87 | |
Neurocrine Biosciences (NBIX) | 0.7 | $107M | 1.2M | 86.55 | |
EXACT Sciences Corporation (EXAS) | 0.7 | $107M | 1.8M | 58.00 | |
Ra Pharmaceuticals | 0.6 | $101M | 2.1M | 48.01 | |
Madrigal Pharmaceuticals (MDGL) | 0.6 | $100M | 1.5M | 66.76 | |
Myokardia | 0.5 | $83M | 1.8M | 46.88 | |
Heron Therapeutics (HRTX) | 0.4 | $71M | 6.0M | 11.74 | |
Cerus Corporation (CERS) | 0.4 | $64M | 14M | 4.65 | |
Zymeworks | 0.4 | $61M | 1.7M | 35.47 | |
Tricida | 0.4 | $59M | 2.7M | 22.00 | |
Atreca Inc Cl A (BCEL) | 0.4 | $59M | 3.5M | 16.55 | |
Dbv Technologies S A (DBVT) | 0.4 | $57M | 15M | 3.92 | |
Axsome Therapeutics (AXSM) | 0.3 | $52M | 890k | 58.83 | |
Insmed (INSM) | 0.3 | $49M | 3.0M | 16.03 | |
Kiniksa Pharmaceuticals (KNSA) | 0.3 | $43M | 2.8M | 15.48 | |
Rhythm Pharmaceuticals (RYTM) | 0.3 | $41M | 2.7M | 15.22 | |
Krystal Biotech (KRYS) | 0.3 | $41M | 947k | 43.24 | |
Neurocrine Biosciences Inc Note 2.250 5/1 | 0.2 | $39M | 31M | 1.28 | |
Neoleukin Therapeutics | 0.2 | $39M | 3.4M | 11.38 | |
Chemocentryx | 0.2 | $35M | 859k | 40.18 | |
Allakos (ALLK) | 0.2 | $33M | 736k | 44.49 | |
Gw Pharmaceuticals Plc ads | 0.2 | $33M | 371k | 87.57 | |
Aurinia Pharmaceuticals (AUPH) | 0.2 | $25M | 1.7M | 14.51 | |
Merus N V (MRUS) | 0.2 | $25M | 2.0M | 12.10 | |
Apellis Pharmaceuticals (APLS) | 0.1 | $24M | 897k | 26.79 | |
Assembly Biosciences | 0.1 | $23M | 1.5M | 14.83 | |
BioCryst Pharmaceuticals (BCRX) | 0.1 | $22M | 11M | 2.00 | |
Frequency Therapeutics | 0.1 | $21M | 1.2M | 17.81 | |
Adaptive Biotechnologies Cor (ADPT) | 0.1 | $21M | 744k | 27.78 | |
Alkermes (ALKS) | 0.1 | $18M | 1.2M | 14.42 | |
Uniqure Nv (QURE) | 0.1 | $17M | 357k | 47.45 | |
Biomarin Pharma Inc convertible/ | 0.1 | $16M | 15M | 1.04 | |
Xencor (XNCR) | 0.1 | $13M | 428k | 29.88 | |
Urogen Pharma (URGN) | 0.1 | $12M | 673k | 17.84 | |
Protagonist Therapeutics (PTGX) | 0.1 | $12M | 1.7M | 7.06 | |
Adaptimmune Therapeutics (ADAP) | 0.1 | $10M | 3.7M | 2.72 | |
Aimmune Therapeutics | 0.1 | $9.7M | 674k | 14.42 | |
Urovant Sciences | 0.1 | $9.2M | 1.0M | 9.22 | |
Mirum Pharmaceuticals (MIRM) | 0.1 | $8.2M | 583k | 14.00 | |
Reata Pharmaceuticals Inc Cl A | 0.0 | $8.1M | 56k | 144.35 | |
Aeglea Biotherapeutics | 0.0 | $8.0M | 1.7M | 4.66 | |
Inflarx Nv (IFRX) | 0.0 | $6.8M | 1.8M | 3.82 | |
Alector (ALEC) | 0.0 | $6.8M | 280k | 24.13 | |
Sangamo Biosciences (SGMO) | 0.0 | $6.4M | 1000k | 6.37 | |
BioDelivery Sciences International | 0.0 | $6.2M | 1.6M | 3.79 | |
Fulgent Genetics (FLGT) | 0.0 | $6.1M | 569k | 10.76 | |
Idera Pharmaceuticals | 0.0 | $6.1M | 4.6M | 1.32 | |
Albireo Pharma | 0.0 | $6.0M | 369k | 16.37 | |
Horizon Therapeutics | 0.0 | $5.9M | 200k | 29.62 | |
Hookipa Pharma Inc equity (HOOK) | 0.0 | $5.8M | 701k | 8.25 | |
Iveric Bio | 0.0 | $5.6M | 1.6M | 3.44 | |
Cabaletta Bio (CABA) | 0.0 | $4.6M | 636k | 7.30 | |
Artara Therapeutics | 0.0 | $4.6M | 200k | 23.00 | |
Millendo Therapeutics | 0.0 | $4.4M | 833k | 5.28 | |
Passage Bio (PASG) | 0.0 | $4.3M | 275k | 15.75 | |
Constellation Pharmceticls I | 0.0 | $4.2M | 133k | 31.43 | |
Immunomedics | 0.0 | $4.2M | 310k | 13.48 | |
Minerva Neurosciences | 0.0 | $4.1M | 689k | 6.02 | |
Syros Pharmaceuticals | 0.0 | $4.1M | 690k | 5.93 | |
Catalyst Pharmaceutical Partners (CPRX) | 0.0 | $4.1M | 1.1M | 3.85 | |
Abeona Therapeutics | 0.0 | $3.3M | 1.6M | 2.10 | |
Anaptysbio Inc Common (ANAB) | 0.0 | $3.3M | 235k | 14.13 | |
Evofem Biosciences | 0.0 | $3.3M | 621k | 5.32 | |
Molecular Templates | 0.0 | $3.2M | 238k | 13.29 | |
Ngm Biopharmaceuticals (NGM) | 0.0 | $3.1M | 250k | 12.33 | |
Orchard Therapeutics Plc ads | 0.0 | $3.1M | 406k | 7.53 | |
Karuna Therapeutics Ord | 0.0 | $3.0M | 42k | 71.99 | |
Aravive | 0.0 | $2.8M | 486k | 5.76 | |
Marker Therapeutics Ord | 0.0 | $2.8M | 1.5M | 1.90 | |
Crinetics Pharmaceuticals In (CRNX) | 0.0 | $2.6M | 175k | 14.70 | |
Galapagos Nv- (GLPG) | 0.0 | $2.6M | 13k | 195.91 | |
Acceleron Pharma | 0.0 | $2.4M | 27k | 89.85 | |
Global Blood Therapeutics In | 0.0 | $2.4M | 47k | 51.09 | |
Harpoon Therapeutics | 0.0 | $2.4M | 205k | 11.58 | |
Matinas Biopharma Holdings, In (MTNB) | 0.0 | $2.3M | 3.8M | 0.60 | |
Applied Therapeutics (APLT) | 0.0 | $2.2M | 66k | 32.68 | |
Viking Therapeutics (VKTX) | 0.0 | $2.0M | 425k | 4.68 | |
Bluebird Bio (BLUE) | 0.0 | $1.8M | 40k | 45.95 | |
Denali Therapeutics (DNLI) | 0.0 | $1.8M | 105k | 17.51 | |
Arcus Biosciences Incorporated (RCUS) | 0.0 | $1.7M | 122k | 13.88 | |
Menlo Therapeutics | 0.0 | $1.7M | 625k | 2.68 | |
Intellia Therapeutics (NTLA) | 0.0 | $1.6M | 129k | 12.23 | |
Leap Therapeutics | 0.0 | $1.5M | 979k | 1.58 | |
Arya Sciences Acquisition-a shs cl a | 0.0 | $1.5M | 150k | 10.18 | |
Dicerna Pharmaceuticals | 0.0 | $1.5M | 82k | 18.37 | |
Bellicum Pharmaceuticals | 0.0 | $1.2M | 249k | 4.71 | |
G1 Therapeutics (GTHX) | 0.0 | $970k | 88k | 11.02 | |
Autolus Therapeutics Plc spon ads (AUTL) | 0.0 | $939k | 157k | 5.99 | |
Galmed Pharmaceuticals | 0.0 | $746k | 216k | 3.46 | |
Ideaya Biosciences (IDYA) | 0.0 | $522k | 127k | 4.12 | |
Adamas Pharmaceuticals | 0.0 | $499k | 173k | 2.89 | |
Infinity Pharmaceuticals (INFIQ) | 0.0 | $486k | 580k | 0.84 | |
Genfit S A ads (GNFT) | 0.0 | $395k | 27k | 14.80 | |
Affimed Therapeutics B V | 0.0 | $316k | 200k | 1.58 | |
Sunesis Pharmaceuticals Inc Ne | 0.0 | $231k | 557k | 0.41 | |
Ovid Therapeutics (OVID) | 0.0 | $207k | 70k | 2.98 | |
Cytomx Therapeutics (CTMX) | 0.0 | $153k | 20k | 7.65 |